| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/02/2006 | US20060024761 Protein biopolymer markers predictive of alzheimer's disease |
| 02/02/2006 | US20060024760 Human brain carboxypeptidase B |
| 02/02/2006 | US20060024759 Complex of a chaperone with beta-amyloid and methods employing this complex |
| 02/02/2006 | US20060024758 Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs |
| 02/02/2006 | US20060024757 Detection of oncofetal fibronectin for selection of concepti |
| 02/02/2006 | US20060024756 Methods and algorithms for cell enumeration in low-cost cytometer |
| 02/02/2006 | US20060024755 Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons |
| 02/02/2006 | US20060024754 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 02/02/2006 | US20060024753 Immunoglobulin-positive neurons in Alzheimer disease are dying via the classical, antibody-dependent, complement pathway |
| 02/02/2006 | US20060024752 Active metabolites of cyclophosphamide that is protected N,N-bis(2-chloroethyl)-O-(2-formylethyl)phosphorodiamidate that may be modified for conjugation to a carrier such as a polyamine, including reagents and immunogens thereof and monoclonal antibodies |
| 02/02/2006 | US20060024751 Scale-up methods and systems for performing the same |
| 02/02/2006 | US20060024750 identification of the natural ligand for the orphan G-Protein Coupled Receptor; diagnosis of conditions involving dysregulated receptor activity |
| 02/02/2006 | US20060024749 Measuring the level of NR2A and/or NR2B NMDA receptor within three hours after stroke onset; for diagnosing stroke in an emergency room setting |
| 02/02/2006 | US20060024748 Cytoxan antibodies and immunoassay |
| 02/02/2006 | US20060024747 Comprises nucleotide sequences coding nitrillase and amidase for transformation and propagation of microorganism capable of catalyzing hydration of certain nitrites to corresponding amides and amides to corresponding carboxylic acids |
| 02/02/2006 | US20060024746 Methods and devices for optical monitoring and rapid analysis of drying droplets |
| 02/02/2006 | US20060024745 Variants of factor XllA |
| 02/02/2006 | US20060024744 Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte |
| 02/02/2006 | US20060024743 Probes labeled with energy transfer coupled dyes |
| 02/02/2006 | US20060024741 Support for fixing nucleotide and process for producing the same |
| 02/02/2006 | US20060024738 Site- or sequence-specific process for cleaving analytes and library of analytes |
| 02/02/2006 | US20060024737 Endocnucleases; real time detection; enzyme resistance; chimera |
| 02/02/2006 | US20060024736 Methods of detection employing immuno-Q-Amp technology |
| 02/02/2006 | US20060024735 Chimeric nucleic acid constructs and compositions comprising sets of nucleic acid constructs |
| 02/02/2006 | US20060024734 MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia |
| 02/02/2006 | US20060024732 Microdevices having a preferential axis of magnetization and uses thereof |
| 02/02/2006 | US20060024729 Mechanosensitive mammalian potassium channels activatable by polyunsaturated fatty acids and the use of said channels in drug screening |
| 02/02/2006 | US20060024728 GM-CSF and/or defensin protein expression regulators in epithelial cells comprising ETS transcription factor or gene encoding the same |
| 02/02/2006 | US20060024726 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 02/02/2006 | US20060024725 Oncofetal fibronectin as a marker for pregnancy-related indications |
| 02/02/2006 | US20060024724 Oncofetal fibronectin as a marker for health and disease |
| 02/02/2006 | US20060024723 Methods for detecting oncofetal fibronectin |
| 02/02/2006 | US20060024722 Samples for detection of oncofetal fibronectin and uses thereof |
| 02/02/2006 | US20060024720 Multiplex data acquisition modes for ion mobility-mass spectrometry |
| 02/02/2006 | US20060024719 Determining MRP-8/14 protein or haptoglobin presence in fluid or tissue sample in patient without interfering condition such as cancer, meningitis, pneumonia, tuberculosis, septicemia, rheumatic arthritis, inflammatory bowel disease, AIDS; or periodontal, skin or gastrointestinal disorders; immunoassay |
| 02/02/2006 | US20060024718 Systems and methods of analyzing nucleic acid polymers and related components |
| 02/02/2006 | US20060024717 Apparatus comprising data analysis module operative to receive one or more signals from the detector for use in determining order of preferential nucleotide sequence |
| 02/02/2006 | US20060024710 Method and device for identifying germs |
| 02/02/2006 | US20060024707 Luminescent polymers and methods of use thereof |
| 02/02/2006 | US20060024705 Molecular analysis of hair follicles for disease |
| 02/02/2006 | US20060024704 Detection of markers in nascent proteins |
| 02/02/2006 | US20060024699 Method for evaluating a substance capable of effecting on endoplasmic reticulum stress-and/or amyloid beta-induced apoptosis |
| 02/02/2006 | US20060024697 Compositions and methods for binding agglomeration proteins |
| 02/02/2006 | US20060024696 Nucleic acid and polypeptide sequences from Lawsonia intracellularis and methods of using |
| 02/02/2006 | US20060024694 bioassays for identifying modulators of retroviral integration via the ataxia telangiectasia mutated(ATM) and Rad3 related kinase pathway; drug screening |
| 02/02/2006 | US20060024691 Novel pathways in the etiology of cancer |
| 02/02/2006 | US20060024690 Normalization of data using controls |
| 02/02/2006 | US20060024688 Alterations of fibulin genes in macular degeneration |
| 02/02/2006 | US20060024687 In vitro evolution of nucleic acids and encoded polypeptide |
| 02/02/2006 | US20060024686 Detection of human papillomaviruses |
| 02/02/2006 | US20060024683 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 02/02/2006 | US20060024679 Method for predicting the expression efficiency in cell-free expression systems |
| 02/02/2006 | US20060024673 Slc2as as modifiers of the p53 pathway and methods of use |
| 02/02/2006 | US20060024671 Biopolymer marker indicative of disease state having a molecular weight of 1525 daltons |
| 02/02/2006 | US20060024669 Using influenza virus peptide as tool in diagnosis and treatment of viral diseases; proteomics; bioinformatics |
| 02/02/2006 | US20060024668 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/02/2006 | US20060024664 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 02/02/2006 | US20060024663 Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase |
| 02/02/2006 | US20060024660 Method for relative quantification of proteins |
| 02/02/2006 | US20060024659 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 02/02/2006 | US20060024323 Active immunization using a siderophore receptor protein |
| 02/02/2006 | US20060024321 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies |
| 02/02/2006 | US20060024311 Administering anti-TK1 antibody conjugated to cytotoxic agent consisting of pokeweed antiviral protein (PAP), ricin, abrin, gelonin, saporin, and alpha-sarcin; detecting and diagnosing viral infections |
| 02/02/2006 | US20060024306 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 02/02/2006 | US20060024305 Camp-regulated phosphoprotein for diagnostic and therapeutic use in neurodegenerative diseases |
| 02/02/2006 | US20060024299 Human osteoclast derived cathepsin |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024283 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 02/02/2006 | US20060024268 Modulation of immunoglobulin production and atopic disorders |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | US20060024230 Customized therapeutics and in situ diagnostics |
| 02/02/2006 | US20060024201 Flexible reactor |
| 02/02/2006 | US20060022400 Sheet material information-detecting apparatus |
| 02/02/2006 | US20060022129 Peptide mass spectrometry rich in daughter ions |
| 02/02/2006 | US20060021940 Method and device for integrated analysis of a hydrocarbon sample |
| 02/02/2006 | DE202005015571U1 Rock mass`s e.g. saliniferous rock, ground pressure determination device for mining industry, has sensor to determine pressure based on reflections of ultrasonic waves in ultrasonic path formed between ultrasonic transmitter and receiver |
| 02/02/2006 | DE112004000505T5 Drucksteuerungssystem zum Drucken eines zähflüssigen Materials The pressure control system for printing a viscous material |
| 02/02/2006 | DE112004000253T5 Adsorption, Detektion und Identifikation von Komponenten der Umgebungsluft mit Desorption/Ionisation auf Silizium und Massenspektrometrie (DIOS-MS) Adsorption, the detection and identification of components of the ambient air with desorption / ionization on silicon and mass spectrometry (DIOS-MS) |
| 02/02/2006 | DE10350484B4 Verfahren und Vorrichtung zur Markierung von Proteinen Method and apparatus for labeling proteins |
| 02/02/2006 | DE102004046724B3 Reaction container, comprises outlet surrounding reaction surface and provides supporting cover unit in order to form reaction chamber by arranging plane central area of cover unit in preset distance to surface |
| 02/02/2006 | DE102004033811A1 Verfahren zum einfachen und schnellen Nachweis von Zellen und Biomolekülen mit Hilfe paramagnetischer Partikel A method for easy and quick detection of cells and biomolecules using paramagnetic particles |
| 02/02/2006 | DE102004033667A1 Kompositmaterialien mit Tetraetherlipiden und deren Herstellung Composite materials with tetraether lipids and their preparation |
| 02/02/2006 | DE102004032196A1 Testkit und Haftklebeband für eine zytologische Untersuchung der Hautoberfläche Test kit and adhesive tape for a cytological examination of the skin surface |
| 02/02/2006 | DE102004030382A1 Strain-measuring method for measuring transverse strain in semiconductor material uses piezoresistive resistors sensitive to transverse and normal strains |
| 02/02/2006 | CA2616277A1 Urine markers for detection of bladder cancer |
| 02/02/2006 | CA2589098A1 Method for diagnosing and treating bone-related diseases |
| 02/02/2006 | CA2575683A1 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 02/02/2006 | CA2575462A1 Mutations in erb2 associated with cancerous phenotypes |
| 02/02/2006 | CA2575356A1 Use of llt1 and/or cd161 for modulating the activity of cells of the immune system |
| 02/02/2006 | CA2575214A1 Substituted triazines as prion protein ligands and their use to detect or remove prions |
| 02/02/2006 | CA2575135A1 Method for analyzing oligomeric proanthocyanidin (opc) |
| 02/02/2006 | CA2575077A1 Immunoassay assembly and methods of use |
| 02/02/2006 | CA2575011A1 Analyzer of phosphorylation of peptide or protein, phosphorylation determination program, and recording medium for the program |
| 02/02/2006 | CA2574991A1 Methods for diagnosis of appendicitis |
| 02/02/2006 | CA2574683A1 Probe complex |
| 02/02/2006 | CA2574663A1 Method for determining the presence of a chemical compound which is homogeneously distributed in a medium by means of cross-correlating a measuring spectrum with reference spectra |
| 02/02/2006 | CA2574654A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/02/2006 | CA2574442A1 Pancreatic polypeptide as target/marker of beta cell failure |
| 02/02/2006 | CA2574432A1 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |